Loss expected for Aptevo Therapeutics By: MarketMinute.com Stock News January 16, 2018 at 16:36 PM EST Analysts expect Aptevo Therapeutics Inc. (Nasdaq: APVO) to fall to a loss for the current quarter. The stock price tumbled $1.25 to close at $3.14. Related Stocks: Aptevo Therapeutics Inc